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Introduction
The human X chromosome is the favorite chromosome of
many geneticists because of its peculiar inheritance pattern
and unique biology. The peculiar inheritance pattern stems
from its hemizygosity in males and gives rise to a
disproportionately high number of Mendelian diseases
associated with a human chromosome. As high as 70% of
the genes with a known function on the X are associated
with disease phenotypes. The unique biology, termed X-
inactivation, describes the transcriptional silencing of one
of its copies in females. A substantial deal of sex
differences in health issues has its origins in the genes on
the X chromosomes and the X-inactivation process [1]. For
example, a single copy of X chromosome in males leads to
their vulnerability to X-linked diseases, such as X-linked
immunological diseases (Bruton agammaglobulinemia and
Wiskott–Aldrich syndrome), Duchenne muscular dystro-
phy, or a variety of X-linked mental retardation syndromes,
such as fragile X syndrome.
X Chromosome and Autoimmune Diseases
The X chromosome is increasingly being more implicated
in the function of the immune system and the development
of autoimmune diseases. For example, forkhead box 3 on
Xp11.23 is a member of the forkhead–winged-helix family
of transcriptional regulators. It has a central role in T-cell
biology, and its germ-line mutations are associated with X-
linked autoimmunity–allergic dysregulation syndrome also
known as immune dysregulation, polyendocrinopathy,
enteropathy, X-linked syndrome [2, 3]. X chromosome is
home to 32 genes, which have a melanoma antigen
(MAGE) domain. Only four other MAGE genes have been
reported in the rest of the genome [4]. The MAGE gene
products are members of the cancer–testis antigen group,
and they are potential targets for tumor immunotherapy [5].
Structural and numerical abnormalities of the X chromo-
some have been implicated in autoimmunity. For example,
X autosome translocations and deletions of the X are
associated with premature ovarian failure [6]. Patients with
monosomy X (Turner’s syndrome) often manifest autoim-
mune features [7].
Female Preponderance in Autoimmune Diseases
It has been recognized more than a century ago that women
are more affected by autoimmune diseases than men [8].
The most striking sex differences are observed in sclero-
derma, autoimmune thyroid disease (Hashimoto’s thyroid-
itis and Graves’ disease), systemic lupus erythematosus,
and Sjögren syndrome, in which the patient population is
greater than 80% women. Other diseases such as rheuma-
toid arthritis, multiple sclerosis, and myasthenia gravis are
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relatively more common in women. And finally, in some
diseases, such as insulin-dependent diabetes mellitus,
subgroups characterized by distinct clinical manifestations
may have female preponderance.
Kast–Stewart Hypothesis
Paths to understanding the genetic basis of autoimmune
diseases have shown that simple Mendelian traits arising
from single-gene mutations and complex traits resulting
from interactions between multiple genotypes and the
environment contribute to the breakdown of self-tolerance.
Important environmental factors include pathogen expo-
sure, pregnancy, and lifestyle. Despite significant advances,
our present day understanding of the mechanisms of self-
tolerance and its breakdown is not complete, and novel
mechanisms including those other than classical patterns of
inheritance may play a critical role. One such mechanism,
first hypothesized by Kast [9] and further developed by
Stewart [10], is disturbances in the X chromosome
inactivation process. The “Kast–Stewart hypothesis” has
its roots in two simple observations; first, an overwhelming
majority of autoimmune diseases are exceedingly more
prevalent in females and, second, X-inactivation is a
fundamental biological regulation that is in effect only in
women. X chromosome inactivation is an epigenetic event
in early development that leads to the transcriptional
silencing of one of the pair of X chromosomes [11].
Therefore, X chromosome inherited by either parent is
silenced at random, and normal women are thus a mosaic of
two cell populations [1]. Although the attractive Kast–
Stewart hypothesis caught the attention of investigators
working on autoimmune diseases, X-inactivation patterns
comparable to those of control women were observed in
peripheral blood from female patients with systemic lupus
erythematosus, juvenile diabetes, multiple sclerosis, and
juvenile rheumatoid arthritis [12].
X-Inactivation in Scleroderma
While working on a male patient with classic Rett
syndrome [13] and reviewing related literature on mosai-
cism [14], the author of this article suspected that extremely
skewed X-inactivation, especially in hematopoietic stem
cells, could be involved in the pathogenesis of scleroderma
(systemic sclerosis). The focus on scleroderma has its roots
on reports [15, 16] which raise the possibility that localized
scleroderma, including the linear and frontal or frontopar-
ietal (en coup de sabre) forms, may follow the lines of
Blaschko [17]. Localized scleroderma is an autoimmune
disorder, [18–20] and interestingly Blaschko’s lines define
dermatome areas which are thought to derive from a single
X-inactivation derivative [21–23]. To test the potential
involvement of skewed X-inactivation in the pathogenesis
of scleroderma, we analyzed the methylation status of a
highly polymorphic CAG repeat in the androgen receptor
gene and demonstrated that X-inactivation mosaicism is
extremely skewed in the blood but not in the skin lesions of
nearly half of a group of 55 females with scleroderma. This
was the first study that established an association between
X-inactivation and female predisposition to autoimmunity
[24]. An extension of this study, which investigates the
parental origin of the inactive X chromosome, is presented
in the accompanying manuscript [25].
X-Inactivation in other Female Prevalent Autoimmune
Diseases
Following the publication of the scleroderma study, several
studies that analyze X-inactivation patterns in female-
prevalent autoimmune diseases have been initiated by our
group and others. According to published results, signifi-
cantly increased proportions of patients with autoimmune
thyroid diseases [26, 27], preeclampsia [28], and premature
ovarian failure [29] display extremely skewed X chromo-
some inactivation, when compared to controls (Table 1).
However, skewing in blood cells was not observed in
individuals with primary biliary cirrhosis [30] and Sjögren’s
syndrome (unpublished observations), which may indicate
that this is probably not a factor in all autoimmune diseases.
Table 1 X-inactivation patterns in patients with autoimmune diseases
and controls
Degree of skewing, No. (%) observed
90+ 80–89 50–79
Disease
SSc-TR (n=70) [24] 27 (49.1) 8 (14.5) 20 (36.4)
SSc-US (n=125) [25] 17 (18.1) 15 (16.0) 62 (66.0)
AITD-TR (n=110) [26] 16 (19.3) 12 (14.5) 55 (66.2)
AITD-Scand. (n=40) [27] 5 (15.6) 6 (18.8) 21 (65.6)
PEE-TR (n=67) [28] 10 (21.7) 6 (13.0) 30 (65.2)
POF-JP (n=43) [29] 5 (18.5) 9 (33.3) 13 (48.1)
Sjögren-TR (n=51) 1 (3.1) 3 (9.1) 29 (87.8)
Controls
Children-TR (n=92) 2 (2.8) 6 (8.3) 64 (88.9)
Newborn-TR (n=91) 2 (3.8) 2 (3.8) 48 (92.3)
Newborn-US (n=590) [42] 4 (0.7) 29 (4.9) 557 (94.4)
Adult-TR (n=160) [24] 3 (2.4) 7 (5.6) 114 (91.9)
Adult-US (n=415) [42] 22 (5.3) 59 (14.2) 334 (80.5)
SSc Scleroderma; AITD autoimmune thyroid diseases; PEE pre-
eclampsia; POF premature ovarian failure; TR Turkey; US United
States; Scand. Scandinavia; JP Japan
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In light of the known causes of primary biliary cirrhosis,
lack of association is not an unexpected finding. Initiation
of autoimmunity in this disease is most probably due to
molecular mimicry [31].
The Cause of Skewed X-Inactivation
At present, we do not know the nature of the relationship
between skewed patterns of X-inactivation and autoimmune
diseases. However, two possibilities could be considered:
skewing may arise as a result of breakdown in self-
tolerance, or breakdown of self-tolerance could be the
result of skewing. We believe the latter is more likely
simply because the degree of skewing is at the extreme of
95:5 or 100:0 in the majority of the patients. If the skewing
were to arise as a result of an autoimmune reaction in the
body, then the ratios would more likely be in the milder
ranges. Monosomy X has been reported as a common
finding in autoimmune diseases including scleroderma and
autoimmune thyroiditis [32]. Could this factor influence the
interpretation of the genotyping results as skewed X-
inactivation? We find this possibility highly unlikely
because skewing is at the extreme range. Therefore, the
attractive “haploinsufficiency hypothesis” [33] may not
apply to scleroderma and autoimmune thyroiditis. It has
been proposed that demethylation of the inactive X
chromosome may explain the female predilection of lupus
[34]. This is a very interesting proposal, and it could be
extrapolated to a “diploid overexpression hypothesis,”
which has the potential to explain why autoimmune
diseases are more prevalent in females. But we find it
difficult to attribute our extremely skewed ratios to
generalized methylation defects because then the demethy-
lation process should be a widespread event on the X,
affecting the expression levels of many genes including
androgen receptor. However, expression profiling did not
reveal a global increase of X-linked genes in scleroderma
[35, 36]. Based on these considerations, we conclude that
deleterious X-linked mutations or X chromosome rear-
rangements and their differential expression patterns could
provide a disadvantage to affected blood cells and lead to
skewed X-inactivation. A circumstantial evidence in sup-
port of this explanation could be the increased incidence of
recurrent spontaneous abortions in the extremely skewed
patients in both scleroderma [24] and autoimmune thyroid-
itis [26]. Recurrent spontaneous abortions are associated
with skewed X-inactivation [37, 38], and an association
between autoimmune diseases and recurrent spontaneous
abortions has been reported [39].
A key point to consider at this point is the location of
these putative X-linked mutations. We propose that they do
not need to be at a certain gene or locus on the
chromosome. On the contrary, any mutation that affects
the viability of the cell could lead to skewed X-inactivation.
In addition, X–autosomal translocations, which fall within
and outside genes [40] or other X chromosome aberrations,
could affect the X-inactivation ratios. Therefore, female
predisposition to autoimmunity could be initiated by a
variety of X chromosomal events including a single
mutation in a very rich repertoire of genes. This may also
explain why despite the extensive linkage genome scans, X
chromosome is not clearly implicated in familial cases of
autoimmune thyroid diseases, [41] or to that effect why a
major locus for autoimmunity proves to be so difficult to
find in the genome. It is probably time to consider “loss of
mosaicism” for X-linked gene expression as the first step of
the cellular events that lead to breakdown of self-tolerance
in females.
Future Perspectives
Although extremely skewed X-inactivation is rare and it is
associated with autoimmune diseases, it does not lead to the
breakdown of self-tolerance in all women. We believe this
point is of paramount importance in identifying the putative
X-linked genes associated with autoimmune diseases and
propose that breakdown of self-tolerance requires the co-
inheritance of two distinct events on the X chromosome:
first, an X-linked mutation leading to “loss of mosaicism”
and second “heterozygosity for allelic variants of the
putative critical genes”. Developing research strategies in
line with the above proposed mechanisms could prove to be
very fruitful in understanding the molecular determinants of
autoimmunity and identify potential targets for therapy.
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